Table 2.
Multivariable predictors of 3D VCA ≥ 0.3 cm2 after TEER at baseline
| Odds ratio estimates and wald confidence intervals | ||||
|---|---|---|---|---|
| Effect | p-value | Estimate | 95% Confidence Limits | |
| Gender (female) | 0.1373 | 0.730 | 0.482 | 1.106 |
| Age (per year) | 0.8526 | 1.002 | 0.977 | 1.029 |
| sPAP per 20 mmHg | 0.0344* | 1.243 | 1.016 | 1.521 |
| Severe MR in baseline TOE | 0.0148* | 2.904 | 1.232 | 6.847 |
| permanent AF | 0.0366* | 1.533 | 1.027 | 2.289 |
| CRT | 0.1872 | 1.437 | 0.839 | 2.461 |
| Mixed disease MR | 0.0925 | 1.549 | 0.930 | 2.581 |
| Non ischemic cardiomyopathy | 0.6138 | 1.124 | 0.713 | 1.771 |
sPAP systolic pulmonary artery pressure, MR mitral regurgitation, AF atrial fibrillation, CRT cardiac resynchronization therapy, MR mitral regurgitation, TOE transesophageal echocardiography. *p < 0.05